| Literature DB >> 32243673 |
Bin Liu1,2,3,4, Yangzhong Wang5, Yuanyuan Zhao1,2,3,4, Huibo Shi1,2,3,4, Fanjun Zeng1,2,3,4, Zhishui Chen1,2,3,4.
Abstract
Coronavirus disease 2019 (COVID-19) pandemic spreads rapidly and may be an increasing challenge for transplant community. Clinical data on COVID-19 infection in transplant population is very limited. Herein we presented the clinical course and outcome of a 50-year-old male post liver transplantation who contracted COVID-19, with subsequent infection of his wife. The process of illness was representative. A therapeutic regime with temporary immunosuppression withdrawal and systemic low-dose corticosteroid as principle was involved in the management of the patient which made him recover from severe COVID-19 pneumonia.Entities:
Keywords: clinical research/practice; immunosuppressant; infection and infectious agents - viral; infectious disease; liver transplantation/hepatology
Mesh：
Substances：
Year: 2020 PMID： 32243673 DOI： 10.1111/ajt.15901
Source DB: PubMed Journal: Am J Transplant ISSN： 1600-6135 Impact factor: 8.086